Basic info
Industry
biotechnology research
Sectors
Biotechnology
AAV gene therapy
CNS disease
AAV capsid variants
Therapeutics
Genetics
AAV manufacturing
AAV capsid engineering
Lysosomal storage disease
Date founded
2017
Funding rounds raised
Total raised
$30M
from 1 investors over 1 rounds
L
Lacerta Therapeutics raised $30M on August 9, 2018
Investors: Sarepta Therapeutics